Yes, clascoterone (Winlevi) is an FDA-approved topical cream for the treatment of acne vulgaris in patients aged 12 and older. Approved on August 26, 2020, it offers a novel mechanism of action by inhibiting androgen receptors in the skin, reducing oil production and inflammation associated with acne.
Clascoterone is a topical medication used for the treatment of acne vulgaris in individuals aged 12 and older. It is part of the drug class of topical acne agents and is applied directly to the skin in the form of a 1% cream.
Clascoterone works by blocking the effects of androgens (male hormones) on the skin's sebaceous (oil) glands. Androgens can increase oil production and inflammation, leading to acne. By inhibiting these hormones, clascoterone helps reduce acne lesions.
Clascoterone is intended for topical use only and should not be ingested. The typical dosage involves applying a thin, uniform layer of the cream to the affected areas twice a day, once in the morning and once in the evening. It is important to follow the prescribed instructions carefully:
Clascoterone can cause a range of side effects, from common to serious:
Common Side Effects:
Serious Side Effects:
If you experience any serious side effects, you should contact your doctor immediately.
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!